Fundisa African Academy of Medicines Development (
FAAMD) is registered as a non-profit Company (Companies and Intellectual Property Commission of South Africa (CIPC), NPC 2014/104973/08; PBO 930054211), and is based in Cape Town, South Africa.
The aim of the Fundisa African Academy of Medicines Development is to provide leadership and capacity building in medicines development and regulation or related sciences by:
- Fostering and promoting teaching and training in South Africa and other African countries;
- Organising workshops and courses;
- Development of young scientists;
- Promoting communication and cooperation between teaching institutions, industry and regulatory agencies.
The
Scientific Advisory Board (SAB) advises on strategic goals, specific
teaching and training initiatives, and networking with professional organisations or
regulatory agencies. Companies,
regulatory agencies and other institutions are invited to join the
Academy Support Organisation.
Together with Pharmacometrics Africa, CP+ Associates and the COVID-19 Clinical Research Coalition, Fundisa African Academy of Medicines Development has presented a webinar on Controlled Human Infection Challenge Studies on 01 September 2020 to discuss:
- Ethical and scientific principles for such studies,
- Risk mitigation steps taken in previous malaria human challenge studies,
- Possible applications and practical concerns in the context of COVID-19 vaccine development.
The presentations and a list of recommended reading material can be found at:
www.pmxafrica.org
